YAYON AVNER has a total of 16 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Israel and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are PROCHON BIOTECH LTD, STUPP SAMUEL I and OCTAPHARMA AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Israel | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Object sterilising | |
#6 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Yayon Avner | 14 |
#2 | Rom Eran | 6 |
#3 | Azachi Malkit | 3 |
#4 | Gladnikoff Micha | 2 |
#5 | Shikhanovich Roman | 1 |
#6 | Barkay Hilla | 1 |
#7 | Callahan Alex B | 1 |
#8 | Blumenstein Sara | 1 |
#9 | Borges Eric | 1 |
#10 | Rozen Nimrod | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019064304A1 | Methods and compositions for treating multiple sclerosis | |
US2010274362A1 | Cartilage particle tissue mixtures optionally combined with a cancellous construct | |
US2010047251A1 | Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof | |
IL182972D0 | Treatment of b-cell malignancies | |
US2009155229A1 | Chondrocyte-based implant for the delivery of therapeutic agents | |
US2009175866A1 | Treatment of b-cell malignancies | |
IL163179A | Porous freeze-dried plasma protein matrices and methods for preparation thereof |